Inactive Instrument

Insiders LYSOGENE

Equities

Lysogene CFO Assumes Same Role at Mauna Kea Technologies	23-06-14	MT
Lysogene: interim CFO confirmed	23-02-06	CF
French Gene Therapy Group Lysogene Makes Ad Interim CFO Permanent	23-02-06	MT
Lysogene Announces New Board of Directors	22-09-16	CI
Lysogene Jumps 14% On New Chief Medical Officer's Appointment	22-02-07	MT
Lysogene Appoints Stéphane Durant des Aulnois as Chief Financial Officer and a Member of the Executive Committee	19-10-17	CI
Lysogene Announces the Appointment of Carole Deffez as New Independent Board Director	19-09-26	CI
Lysogene S.A. Announces Board Changes	19-05-22	CI
Lysogene Announces Management Changes	18-11-15	CI
Lysogene Announces Changes in the Composition of its Board of Directors	18-09-13	CI
Lysogene Announces the Nomination of Dr. Ralph Laufer as Chief Scientific Officer and Member of the Executive Team	18-05-15	CI
Lysogene Announces Board Changes	18-04-23	CI
Lysogene S.A. Appoints Ralph Laufer as Chief Scientific Officer, Effective May 2, 2018	18-04-16	CI
Lysogene Announces Appointments to its Clinical Advisory Board	17-09-12	CI
Lysogene Nominates Philippe Mendels-Flandre as Chief Operating Officer and a Member of the Board of Directors	17-05-16	CI
Lysogene Appoints David Schilansky to Its Board	16-12-07	CI
Lysogene Appoints Kimberley S. Gannon as Chief Scientific Officer	16-06-20	CI
Lysogene Appoints Berndt A. Modig as Senior Financial Advisor and Sarah Ankri as Finance Director	15-11-09	CI
Lysogene Appoints Annette Clancy as Chair of the Board	15-04-20	CI

No results for this search